| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INTRACELLULAR SIGNAL SYSTEMS |
School of Dentistry, National Taiwan University College of Medicine (B.Y.L., P.W.W., J.T.W.), Taipei, Taiwan 10016, Republic of China.; Department of Dentistry, National Taiwan University Hospital (B.Y.L., J.T.W.), Taipei, Taiwan 10016, Republic of China; and Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School (F.R.B.), Boston, Massachusetts 02114
Address all correspondence and requests for reprints to: Dr. Bu-Yuan Liu, Department of Dentistry, National Taiwan University Hospital, 1 Chang-Te Street, Taipei, Taiwan 10016, Republic of China. E-mail: byliu{at}ha.mc.ntu.edu.tw
Estrogens modulate the catabolic effects of PTH on bone in vivo and in vitro. PTH-stimulated cAMP accumulation in osteoblasts is thought to be linked to increased osteoclastic activity, but the precise mechanism is still unknown. In cocultures of clonal marrow stromal cells (MS1) and normal mouse spleen cells, both 1,25-dihydroxyvitamin D3 and rat PTH (rPTH)-(134) can induce the formation of tartrate-resistant acid phosphatase- and calcitonin receptor-positive multinucleated osteoclast-like cells, which can attach to dentine slices and produce resorption pits. In this system, osteoclastogenesis stimulated by PTH, but not by 1,25-dihydroxyvitamin D3, was suppressed by 17ß-E2 (10-1010-8 M), whereas 17
-E2 (10-8 M) had no effect. Exposure to 10-8 M 17ß-E2, but not 17
-E2, also significantly decreased the PTH-induced attachment of osteoclast-like cells to dentine slices. 17ß-E2 inhibited osteoclast-like cell formation induced by 8-bromo-cAMP (10-4 M), 12-O-tetradecanoylphorbol 13-acetate (10-8 M), or rat PTH-(134) (10-7 M) in combination with either rp-adenosine-3',5'-cyclic monophosphorothioate (10-4 M) or 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (10-5 M). 17ß-E2 suppressed the partial stimulation of tartrate-resistant acid phosphatase-positive multinucleated osteoclast-like cell formation induced by [Arg2]human (h) PTH-(134) (10-7 M) or hPTH-(334) (10-7 M), but not that caused by 10-7 M hPTH-(5384). We conclude that estrogens suppress PTH-stimulated osteoclast-like cell formation by blocking both the cAMP-dependent PKA pathway and the PLC-coupled calcium/PKC pathway. In addition to inhibiting formation of osteoclasts and promoting their apoptosis, estrogen may regulate bone resorption by blocking attachment of osteoclasts to bone.
This article has been cited by other articles:
![]() |
T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, R. L. Jilka, S. C. Manolagas, and C. A. O'Brien Parathyroid Hormone Stimulates Receptor Activator of NFkappa B Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding Protein J. Biol. Chem., December 6, 2002; 277(50): 48868 - 48875. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |